AMBROSE KRISTEN (SVP & Chief Accounting Officer) sold 22.1% of their position (2.19K shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $1.06M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/19/2026ACC: 0000875320-26-000080
Officer· SVP & Chief Accounting Officer
Since May 2021
-984.00
Net shares
Net seller
$1.35M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
1.81K acquired · 2.79K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+1.81K
Price / share
—
Trade value
—
% of position
20.7%
2/17/2026
8.73K→10.54K
Common Stock
Direct
Shares
−598.00
Price / share
$483.75
Trade value
$289.28K
% of position
5.7%
2/17/2026
10.54K→9.95K
Common Stock
Direct
Shares
−1.56K
Price / share
$489.46
Trade value
$762.09K
% of position
15.7%
2/17/2026
9.95K→8.39K
Common Stock
Direct
Shares
−638.00
Price / share
$473.68
Trade value
$302.21K
% of position
7.6%
2/18/2026
8.39K→7.75K
Total
Net shares
−984.00
Net value
-$1.35M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/17/2026 | A · Award | +1.81K | — | — | 20.7% | 8.73K | 10.54K |
| Common Stock Direct | 2/17/2026 | F · Tax Withholding | −598.00 | $483.75 | $289.28K | 5.7% | 10.54K | 9.95K |
| Common Stock Direct | 2/17/2026 | S · Sale | −1.56K | $489.46 | $762.09K | 15.7% | 9.95K | 8.39K |
| Common Stock Direct | 2/18/2026 | S · Sale | −638.00 | $473.68 | $302.21K | 7.6% | 8.39K | 7.75K |
| Total | −984.00 | -$1.35M | ||||||
Derivative Transactions0
No derivative transactions reported